New SEC Form D filing
Abcuro, Inc., 2026-08-13
A new SEC Form D private-offering notice from Newton, MA, a $176,522,953 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Clinical stage biotechnology company developing immunotherapies targeting cytotoxic T cells for autoimmune diseases and certain cancers.
Filed 6 days agoFiled to raise $176,522,953First money in 2026-08-07Raised so far $39,383,108HQ (as filed) Newton, MASector Biotech web-verified against the company’s own siteStage (inferred) Late
Source linked the Form D on EDGAR↗Website verified abcuro.com↗Named in the filing 6 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Carnot Labs, Inc., 2026-08-13, $8.1M, Charlestown, MA
- iReprogram, Inc, 2026-08-13, $25M, Ann Arbor, MI
- HYKU BIOSCIENCES INC., 2026-08-13, $8.6M, Concord, MA
- Auron Therapeutics, Inc., 2026-08-13, $12M, Wellesley, MA
- Rapid Liquid Print Co., 2026-08-12, $2.2M, Charlestown, MA
- Trace Biosciences Inc., 2026-08-12, $16.2M, Beaverton, OR
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.